IMDX - Insight Molecular Diagnostics Inc.

Momentum: Bearish

Recent News

iMDx to Participate in NYC Investment Conferences September 8 - 11

GlobeNewswire • 2 weeks, 5 days ago • score: 0.31

NASHVILLE, Tenn., Aug. 26, 2025 ( GLOBE NEWSWIRE ) -- Insight Molecular Diagnostics Inc., or iMDx, ( Nasdaq: IMDX ) , today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street Capital Markets. Information for each can be found below: ...

Bullish

IMDX CFO Andrea James Featured in Empowered Patient Podcast on Democratizing Molecular Diagnostics - Insight Molecular ( NASDAQ:IMDX )

Benzinga • 3 weeks ago • score: 0.35

BOSTON, Aug. 25, 2025 ( GLOBE NEWSWIRE ) -- The Empowered Patient Podcast with Karen Jagoda recently featured Andrea James, Chief Financial Officer of Insight Molecular Diagnostics, Inc. ( iMDx ) IMDX, in an episode on "Democratizing Molecular Diagnostics: Transforming Transplant Success."

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

OncoCyte Corporation is a precision diagnostics company in the United States and internationally. The company is headquartered in Irvine, California.

52W High

$4.75

52W Low

$1.92

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

0.99

Valuation

As of 2025-03-31 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-1.25

EV/Revenue (<3 favorable)

14.11

P/S (TTM) (<3 favorable)

22.55

P/B (<3 favorable)

8.00

Ownership

Balanced

Source: Overview

Insiders (1–5% typical)

22.03%

Institutions (25–75% balanced)

56.30%

Shares Outstanding

28,599,300

Float

7,755,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-03-31 (Overview)

Revenue (TTM)

3,843,000

Gross Profit (TTM)

2,093,000

EPS (TTM)

-3.79

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

-2.73%

ROE (TTM) (>15% strong)

-4.29%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

11.15

Momentum

Bearish momentum

Value

0.1039

0.0711

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025